Where urethral stricture treatment is heading
Urethral stricture · Updated Nov 12, 2026
A urethral stricture is scar tissue that narrows the tube carrying urine. Stretching or cutting it is quick but often fails over time. Reconstructive surgery lasts longer. Research is about making the quick options last, and growing tissue for long strictures.
- 21studies open or running
- 331papers published this year
- 6NIH-funded projects
-
Now
Nov 2026
A drug-coated balloon lasts longerHappened 58% lasting relief at 5 years
Optilume, approved in the US, kept most short strictures open for five years in its first study.
58%: had lasting symptom relief at 5 years without more treatment.
Simple stretching works for someHappened 67.07% success with plain balloons
Balloon dilation without a drug coating succeeded in about two-thirds of men across studies.
67.07%: success rate of simple balloon dilation.
Surgery techniques comparedHappened
Graft placement on the top or bottom of the urethra gives the same results.
-
6 months
by May 2027
Why repeated procedures make it worsePossible
A VA-funded study on how repeated scope procedures lengthen strictures ended its funding in late 2026; papers should follow.
-
12 months
by Nov 2027
Fat-derived cells to stop scarringLong shot
A French trial injects cells taken from the patient's own fat after urethrotomy to reduce scar regrowth. Due November 2027.
-
3 years
by late 2029
Drug-releasing silk graftsLong shot
An NIH-funded team is building silk grafts that release drugs, for long strictures. Funding runs to December 2027.
-
5 years
by late 2031
Lab-grown urethral tissueLong shot
3D-printed, elastic tissue for long strictures may reach first human testing.
The research paths
Making scope treatments last
58% lasting relief at 5 yearsDetails and 1 trialsHide
Drug-coated balloons and injected cells aim to stop scar tissue from growing back after stretching.
WatchRandomized results comparing Optilume with standard treatment.
Better grafts and tissue
DetailsHide
Cheek tissue works well but is limited. Engineered grafts aim to repair long strictures.
WatchFirst tests in people.
Borrowed from other conditions
From Heart and leg arteries
Paclitaxel-coated balloons
Approved
The drug-coated balloons used to keep arteries open, adapted for the urethra.
Open to join now
-
Recurrent stricture, France
Fat-derived cells after urethrotomy
Locations and eligibility →
See every recruiting urethral stricture trial →
When the trials finish
Completion dates the trials registered. Results usually follow 3 to 12 months later.
- Heating up
- Maturing
- Early
- Cooling
- Fully enrolled, waiting on results
- Still enrolling
Knowledge on the way
Not treatments yet: detection, causes and how care is delivered. Mostly NIH-funded.
- AreaQuestionFunded throughNews likely
- Care Drug-releasing silk grafts for long urethral stricturesUC Irvine · NIH Funded through Dec 2027 News likely 2027–2028
- Biology 3D-printed elastic urethral tissueUCLA · NIH Funded through May 2026 (ended) News likely Final papers 2026–2027
- Care How repeated procedures make strictures worseVA San Diego · NIH Funded through Sep 2026 (ended) News likely Final papers 2026–2027
What just happened
Drug-coated balloon: 58% relief at 5 years
ROBUST I, 53 men.
Standard treatment today
- Short, first strictureDilation or urethrotomy (a cut made through a scope), or the Optilume drug-coated balloon.
- Returns after scope treatmentUrethroplasty, open reconstructive surgery, often with a graft from the inside of the cheek.
- Long or complexStaged urethroplasty at a specialist center.
How to read this page, and sourcesHow to read this page, and sources
- There are very few randomized trials in this condition; most studies follow one group of patients.
- Completion dates are what each trial registered. Results usually follow 3 to 12 months later.
- Forecasts are editorial judgments by Find a Trial, not predictions from sponsors or regulators.
See urethral stricture trials recruiting now →